Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.57 |
| ▸ | RAD52 | P43351 | 2/20 | 0.57 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.40 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.40 |
| ▸ | LSS | P48449 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6243130 | 1.00 | DNM1 (0.59) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Mecetronium SCHEMBL125030 | 1.00 | DNM1 (0.59) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL608118 | 1.00 | DNM1 (0.59) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL6900640 | 1.00 | DNM1 (0.59) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL2904189 | 1.00 | DNM1 (0.59) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL12760650 | 1.00 | DNM1 (0.59) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Hydrochloric Acid SCHEMBL20496970 | 0.98 | DNM1 (0.57) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Mecetronium SCHEMBL11855665 | 0.97 | DNM1 (0.55) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL14742775 | 0.95 | BBOX1 (0.55) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL14743251 | 0.95 | BBOX1 (0.55) | DNM1HTTKMT2AHSP90AA1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12009137-B2 | Magnetic particles, dust core, and coil component | MURATA MANUFACTURING CO., LTD. (JP) | 2024-06-11 | — | — | US | claimed |
| US-20180087006-A1 | CLEANING SOLUTION AND CLEANING METHOD FOR MATERIAL COMPRISING CARBON-INCORPORATED SILICON OXIDE FOR USE IN RECYCLING WAFER | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2018-03-29 | — | — | US | claimed |
| EP-3285285-A1 | CLEANING LIQUID FOR MATERIAL COMPRISING CARBON-CONTAINING SILICON OXIDE FOR WAFER RECYCLING, AND CLEANING METHOD | Mitsubishi Gas Chemical Company, Inc. (JP) | 2018-02-21 | — | — | EP | claimed |
| US-9279055-B2 | Chromate-free corrosion protection for fuel tanks | MANKIEWICZ GEBR. & CO. GMBH & CO. KG (DE) | 2016-03-08 | — | — | US | claimed |
| EP-2181596-B1 | METHOD OF INHIBITING THE GROWTH OF MICROORGANISM IN AQUEOUS SYSTEMS USING A COMPOSITION COMPRISING LYSOZYME | BUCKMAN LABOR INC (US) | 2015-07-08 | — | — | EP | claimed |
| WO-2007100514-A1 | HALOPEROXIDASE TREATMENT TO CONTROL ALGAE | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 2007-09-07 | — | — | WO | claimed |
| US-20070197388-A1 | Haloperoxidase treatment to control algae | BUCKMAN LABORATORIES INTERNATIONAL, INC. | 2007-08-23 | — | — | US | claimed |
| EP-1027880-B1 | Use of quaternary ammonium compounds as antiperspirants | BEIERSDORF AG (DE) | 2005-07-13 | — | — | EP | claimed |
| EP-1080715-A2 | Combination of active agents and compositions for foot-care containing it | Bode Chemie GmbH & Co. (DE) | 2001-03-07 | — | — | EP | claimed |
| EP-1027880-A2 | Use of quaternary ammonium compounds as antiperspirants | Beiersdorf Aktiengesellschaft (DE) | 2000-08-16 | — | — | EP | claimed |
| EP-0293192-B1 | DIESEL FUEL COMPOSITION | EXXON CHEMICAL PATENTS INC. (US) | 1991-11-06 | — | — | EP | claimed |
| US-4764527-A | Hydroxypyrazole derivatives, composition containing them and their use against microorganisms | BASF AKTIENGESELLSCHAFT (DE) | 1988-08-16 | — | — | US | claimed |
| US-4267077-A | CATIONIC SURFACTANT, ANIONIC SURFACTANT AND A SOLVENT; SOFTENING AND ANTISTATIC | KAO SOAP CO., LTD. (JP) | 1981-05-12 | — | — | US | claimed |
| US-3930792-A | NITROAMINOBENZENE, QUATERNARY AMINE, N-OXYALKYLATED FATTY ACID AMIDES | CLAIROL INCORPORATED (US) | 1976-01-06 | — | — | US | claimed |
| JP-11060967-A | — | — | None | — | — | JP | disclosed |
| US-12630728-B2 | Ink set and recording method | SEIKO EPSON CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12584030-B2 | Ink jet ink composition and recording method | SEIKO EPSON CORPORATION (JP) | 2026-03-24 | — | — | US | disclosed |
| US-4165375-A | Low-foaming disinfecting agents based on quaternary ammonium compounds | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1979-08-21 | — | — | US | disclosed |
| US-3998778-A | CONTAINING CARBON BLACK | CHEMISCHE WERKE HULS AKTIENGESELLSCHAFT (DT) | 1976-12-21 | — | — | US | disclosed |
| US-3930792-A | NITROAMINOBENZENE, QUATERNARY AMINE, N-OXYALKYLATED FATTY ACID AMIDES | CLAIROL INCORPORATED (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630728-B2 | Ink set and recording method | DOT1L, SET, ALKBH3 | DNM1 3651/4885HTT 602/4885KMT2A 436/4885 |
| US-12584030-B2 | Ink jet ink composition and recording method | LSM8, SMURF1, SMAD3 | DNM1 1321/4885HTT 2082/4885KMT2A 1630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.